KE2820A - Novel triamcinolone derivative - Google Patents

Novel triamcinolone derivative

Info

Publication number
KE2820A
KE2820A KE2820A KE282078A KE2820A KE 2820 A KE2820 A KE 2820A KE 2820 A KE2820 A KE 2820A KE 282078 A KE282078 A KE 282078A KE 2820 A KE2820 A KE 2820A
Authority
KE
Kenya
Prior art keywords
triamcinolone derivative
novel triamcinolone
novel
derivative
triamcinolone
Prior art date
Application number
KE2820A
Other languages
English (en)
Inventor
G M Sieger
W Shultz
Ch Krieger
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of KE2820A publication Critical patent/KE2820A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KE2820A 1973-08-17 1978-02-28 Novel triamcinolone derivative KE2820A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38930273A 1973-08-17 1973-08-17

Publications (1)

Publication Number Publication Date
KE2820A true KE2820A (en) 1978-03-10

Family

ID=23537694

Family Applications (1)

Application Number Title Priority Date Filing Date
KE2820A KE2820A (en) 1973-08-17 1978-02-28 Novel triamcinolone derivative

Country Status (17)

Country Link
US (1) US4158055A (fr)
JP (1) JPS557407B2 (fr)
BE (1) BE818929A (fr)
CH (1) CH601353A5 (fr)
CY (1) CY946A (fr)
DE (1) DE2437847C3 (fr)
FR (1) FR2240738B1 (fr)
GB (1) GB1442925A (fr)
HK (1) HK44778A (fr)
HU (1) HU172213B (fr)
IE (1) IE39738B1 (fr)
IL (1) IL45200A (fr)
KE (1) KE2820A (fr)
MY (1) MY7800234A (fr)
NL (1) NL184899C (fr)
PH (1) PH12415A (fr)
ZA (1) ZA744259B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA763131B (en) * 1975-05-27 1978-01-25 Syntex Inc Use of flunisolide to treat respiratory diseases
DE10326899A1 (de) * 2003-06-14 2004-12-30 Beiersdorf Ag Kosmetische Zubereitungen mit stabilisierten Konservierungsmitteln
NZ545748A (en) * 2003-08-29 2010-03-26 Ranbaxy Lab Ltd Isoxazoline derivatives as inhibitors of phosphodiesterase type-IV
WO2005028495A1 (fr) * 2003-09-24 2005-03-31 Glaxo Group Limited Glucocorticoïdes anti-inflammatoires
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
EP1934219A1 (fr) 2005-09-16 2008-06-25 Ranbaxy Laboratories Limited Pyrazolo[3,4-b]pyridines substituees en tant qu'inhibiteurs de la phosphodiesterase
WO2007045980A1 (fr) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de la phosphodiesterase de type iv
BRPI0617674A2 (pt) 2005-10-19 2011-08-02 Ranbaxy Lab Ltd composições farmacêuticas e seus usos
CN101616901A (zh) * 2006-09-22 2009-12-30 兰贝克赛实验室有限公司 Iv型磷酸二酯酶的抑制剂
WO2008035316A2 (fr) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibiteurs de phosphodiestérase
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
CN101801376A (zh) * 2007-03-14 2010-08-11 兰贝克赛实验室有限公司 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物
WO2008111009A1 (fr) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Dérivés de pyrazolo[3,4-b]pyridine comme inhibiteurs de phosphodiestérases
EP2111861A1 (fr) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de type IV de la phosphodiestérase
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
CN113698448B (zh) * 2021-10-29 2022-02-22 山东谷雨春生物科技有限公司 一种安西奈德的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB894810A (en) * 1959-10-05 1962-04-26 American Cyanamid Co Aqueous pharmaceutical solutions containing anti-inflammatory steroids
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
GB928150A (en) * 1961-02-08 1963-06-06 Upjohn Co Topical pharmaceutical compositions comprising steroids and flavonoids
US3053836A (en) * 1961-07-14 1962-09-11 Olin Mathieson Acetals and ketals of 16alpha, 17alpha-dihydroxyprogesterones
US3541602A (en) * 1968-07-29 1970-11-17 Squibb & Sons Inc Acetonides of 9-halogenated 3beta,11beta,10alpha,17alpha,21-pentahydroxypregnanes
GB1382614A (en) * 1972-01-10 1975-02-05 Squibb & Sons Inc Steroid compositions
US3867528A (en) * 1973-10-11 1975-02-18 American Cyanamid Co Steroidal topical cream base

Also Published As

Publication number Publication date
IE39738L (en) 1975-02-17
JPS557407B2 (fr) 1980-02-25
GB1442925A (en) 1976-07-14
IL45200A (en) 1978-08-31
FR2240738A1 (fr) 1975-03-14
MY7800234A (en) 1978-12-31
ZA744259B (en) 1975-06-25
CH601353A5 (fr) 1978-07-14
FR2240738B1 (fr) 1980-04-11
IL45200A0 (en) 1974-11-29
DE2437847B2 (de) 1980-06-19
NL184899B (nl) 1989-07-03
NL184899C (nl) 1989-12-01
AU7073674A (en) 1976-01-08
NL7410613A (nl) 1975-02-19
HK44778A (en) 1978-08-18
DE2437847A1 (de) 1975-02-27
IE39738B1 (en) 1978-12-20
CY946A (en) 1978-06-23
HU172213B (hu) 1978-07-28
PH12415A (en) 1979-02-07
BE818929A (fr) 1975-02-17
JPS5058211A (fr) 1975-05-21
US4158055A (en) 1979-06-12
DE2437847C3 (de) 1981-03-12

Similar Documents

Publication Publication Date Title
ZA747964B (en) 2-cyclohexene-1-one derivatives
HK13379A (en) Pyrazino-isoquinoline derivatives
ZA744331B (en) 1-hydroxyphenyl-2-amidoalkylaminoesthanol derivatives
PH14530A (en) 7-methoxycephalosporin derivatives
MY7800234A (en) Novel triamcinolone derivative
PH12927A (en) Vingamine derivatives
PH11410A (en) Novel steroids
ZA743706B (en) Azapurinone derivatives
GB1483352A (en) Phenyl-alkenol and-alkanol derivatives
IL43704A0 (en) Lactamimide derivatives
PH12303A (en) Thienotriazolodiazepine derivatives
MY8100185A (en) Dihydroergopeptine derivatives
HK181A (en) Benzylpyrimidine derivatives
ZM7974A1 (en) Nitro-heterocyclic derivatives
ZA744864B (en) Cyclohexane derivatives
ZA743084B (en) Pyrazinoisoquinoline derivative
ZA741229B (en) Nuceleoside derivatives
ZA747612B (en) Anhydrise derivatives
ZA745315B (en) Novel steroids
AU7333774A (en) Arylchalcogeno-hydrocarbon derivatives
GB1408550A (en) Gitoxigenin-digitoxoside derivatives
AU7333674A (en) Arylchalcogeno-hydrocarbon derivatives
IE38121B1 (en) Novel triamcinolone derivative
ZA746518B (en) Bis-thioreido benezne derivatives
ZA741439B (en) Benzenesulfonylurea derivatives